AstraZeneca
Everything filed under sponsors in our medical research coverage, the 6 reports filed on it so far.
FDA approves AstraZeneca's Etcamah for ctDNA-guided breast cancer treatment
The FDA granted accelerated approval to AstraZeneca's camizestrant (Etcamah) for HR-positive, HER2-negative breast cancer patients with an ESR1...
FDA Grants Accelerated Approval to AstraZeneca's Etcamah
The FDA has granted accelerated approval to AstraZeneca's Etcamah for HR-positive, HER2-negative advanced breast cancer with ESR1 mutations.
Alnylam defends silencer drugs after AstraZeneca trial failure
Alnylam defends its RNAi drugs after AstraZeneca's heart disease trial failure, arguing they work even for patients on stabilizer therapies.
AstraZeneca, Amgen's Tezspire succeeds in Phase 3 eosinophilic esophagitis trial
AstraZeneca and Amgen's Tezspire succeeded in a Phase 3 trial for eosinophilic esophagitis, potentially expanding the label for the immunology drug.
AstraZeneca halts cancer drug trial in setback
AstraZeneca halts cancer drug trial in setback. A target trial emulation of adults with serious mental illness (SMI) found GLP-1 receptor agonists...
AstraZeneca Lung Cancer Trial Setback, Falling U.S. Drug Prices
AstraZeneca discontinues a late-stage trial for its experimental drug volrustomig, while prescription drug prices in the U.S. experience a...